Cargando…
Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge
BACKGROUND: Acute coronary syndrome includes life-threatening clinical conditions ranging from unstable angina to non-Q-wave myocardial infarction and Q-wave myocardial infarction that are a major cause of emergency medical care and hospitalization in the United States. The American College of Cardi...
Autores principales: | Lee, Helen Y., Cooke, Catherine E., Robertson, Teisha A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438254/ https://www.ncbi.nlm.nih.gov/pubmed/18439049 http://dx.doi.org/10.18553/jmcp.2008.14.3.271 |
Ejemplares similares
-
Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq
por: Nassr, Ola A., et al.
Publicado: (2019) -
Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: a multicentre study
por: Tra, J., et al.
Publicado: (2015) -
Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
por: Berger, Jeffrey S.
Publicado: (2018) -
Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study
por: Chow, Clara K, et al.
Publicado: (2019) -
New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)